Population pharmacokinetic and pharmacodynamic analysis for time courses of docetaxel-induced neutropenia in Japanese cancer patients

2007 ◽  
Vol 98 (12) ◽  
pp. 1985-1992 ◽  
Author(s):  
Kazuhiro Ozawa ◽  
Hironobu Minami ◽  
Hitoshi Sato
Keyword(s):  
Cancer Patients ◽  
Population Pharmacokinetic ◽  
Pharmacodynamic Analysis ◽  
Time Courses

scholarly journals Population Pharmacokinetic, Pharmacogenetic, and Pharmacodynamic Analysis of Cyclophosphamide in Ethiopian Breast Cancer Patients

2020 ◽  
Vol 11 ◽  
Author(s):  
Jemal Hussien Ahmed ◽  
Eyasu Makonnen ◽  
Ronald Kuteesa Bisaso ◽  
Jackson Kijumba Mukonzo ◽  
Alan Fotoohi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Population Pharmacokinetic ◽  
Breast Cancer Patients ◽  
Pharmacodynamic Analysis

Population Pharmacokinetic–Pharmacodynamic Analysis of Neutropenia in Cancer Patients Receiving PM00104 (Zalypsis®)

2012 ◽  
Vol 51 (11) ◽  
pp. 751-764 ◽  
Author(s):  
Mario González-Sales ◽  
Belén Valenzuela ◽  
Carlos Pérez-Ruixo ◽  
Carlos Fernández Teruel ◽  
Bernardo Miguel-Lillo ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Population Pharmacokinetic ◽  
Pharmacodynamic Analysis

scholarly journals A Population Pharmacokinetic and Pharmacodynamic Analysis of Abemaciclib in a Phase I Clinical Trial in Cancer Patients

2017 ◽  
Vol 57 (3) ◽  
pp. 335-344 ◽  
Author(s):  
Sonya C. Tate ◽  
Amanda K. Sykes ◽  
Palaniappan Kulanthaivel ◽  
Edward M. Chan ◽  
P. Kellie Turner ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Clinical Trial ◽  
Population Pharmacokinetic ◽  
Pharmacodynamic Analysis

scholarly journals A Population Pharmacokinetic Meta‐analysis of Veliparib, a PARP Inhibitor, Across Phase I/II/III Trials in Cancer Patients

2021 ◽  
Author(s):  
Sven Stodtmann ◽  
Silpa Nuthalapati ◽  
Doerthe Eckert ◽  
Sreeneeranj Kasichayanula ◽  
Rujuta Joshi ◽  
...  
Keyword(s):  
Phase I ◽  
Cancer Patients ◽  
Meta Analysis ◽  
Parp Inhibitor ◽  
Population Pharmacokinetic

Population pharmacokinetic and pharmacodynamic modeling of capecitabine and its metabolites in breast cancer patients

2021 ◽  
Author(s):  
Nastja Lunar ◽  
Marie-Christine Etienne-Grimaldi ◽  
Pauline Macaire ◽  
Fabienne Thomas ◽  
Florence Dalenc ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Pharmacodynamic Modeling ◽  
Population Pharmacokinetic ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document